Tech Company Financing Transactions
Tasso Funding Round
Tasso, based in Seattle, raised $100 million in investment from RA Capital, Cedars-Sinai Medical Center and D. E. Shaw Group.
Transaction Overview
Company Name
Announced On
12/21/2021
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series B
Investors
RA Capital (Lead Investor) (Anurag Kondapalli)
Hambrecht Ducera Growth Ventures (Elizabeth Hambrecht)
Proceeds Purpose
Tasso will use the proceeds from the latest funding round to scale manufacturing and operations to meet the increased demand for its signature line of blood collection devices and high-quality, reliable decentralized health testing services.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1631 15th Ave. W 105
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Website
Email Address
Overview
Tasso is a medical device company that is developing the HemoLink, a user-friendly way to self-collect blood for clinical testing that has the potential to fundamentally change how people interface with healthcare. The HemoLink is a device that enables high-quality blood sample collection with one press of a button.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Casavant
Chief Technical Officer
Erwin Berthier
Browse more venture capital transactions:
Prev: 12/21/2021: Taptap Send venture capital transaction
Next: 12/21/2021: Aztec Network venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs